Latest Articles

How can research labs reduce their environmental impact? Technology Networks asked two sustainability experts to find out.

The rise of digital science is reshaping lab sustainability. In this article, experts highlight the need for new standards to account for computing’s growing environmental impact.

Once dismissed as a party drug, MDMA is reemerging as a therapeutic option for treatment-resistant PTSD. Dr. Kenji Hashimoto explores MDMA’s neurobiological, gut–brain and vagus nerve effects while outlining safety, regulatory and clinical questions.

Addressing critical proteomics challenges in the lab, including robust sample preparation, managing batch effects in experimental design, and ensuring data quality integrity for reliable results.

Women with ADHD are often diagnosed years later than men due to less visible symptoms. Hormonal changes during menstruation, pregnancy and menopause can worsen or mask ADHD, complicating diagnosis and care.

Discover how patient-derived stem cell models are transforming neurodegenerative disease research and drug discovery.

In celebration and support of UK Black History Month and this year’s theme, “Standing Firm in Power and Pride,” this article explores diversity in science and how it shapes who leads research and who benefits from it.

Technology Networks spoke with Dr. Cesar Canales to learn more about the molecular insights of ASD and how they are reshaping our understanding.

ADHD affects millions across the lifespan, disrupting school, work and relationships. Once seen as a childhood disorder, it’s now recognized as lifelong. New research reveals genetic, biological and environmental roots.

Dr. Julia Cooney, a medical doctor, founder and CEO of Zest, explores the ethical, clinical and economic reasons why early Alzheimer’s detection is a critical step in the fight against dementia.